Ildong Holdings corrects disclosure on Idience put option contract, names Ildong Pharmaceutical as buyer
Bitget2026/09/30 09:27- Ildong Holdings filed a corrected disclosure on a put-back option contract tied to Idience’s redeemable convertible preferred share issuance.
- The investor was revised to Ildong Pharmaceutical from the previously disclosed Kiwoom-Yuanta 2019 Scale-up fund group.
- Share subscriptions were updated to 8,000,000 shares at KRW 5,000 each, completed across Nov. 6, 2020, Dec. 14, 2020, Jan. 12, 2021.
- A previously disclosed put-back trigger tied to additional fundraising and pipeline targets by Dec. 31, 2022 was removed.
- The remaining special put-back trigger allows a 50% principal buyback if IPO preliminary review filing missed by Dec. 31, 2023.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Besent “Extinguishes Fire”: Rising US Treasury yields are a global phenomenon, dismisses concerns over AI bubble
U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.